MitoRx - Oxford Technology (S)EIS Fund Invests in Seed Round
MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics to reverse mitochondrial dysfunction and arrest the...
top of page
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take two minutes to learn more.
News
- Feb 23, 2022
- 2 min
Neucruit - Oxford Technology SEIS fund invests in Seed Round
Neucruit is an intelligent software that redefines clinical trial recruitment. Their technology aggregate real-time data from over 25...
- Nov 2, 2021
- 6 min
Interview - Ian Quirk
Meet Ian Quirk, CEO and co-founder of Active Needle Technology. Active Needle builds on technology developed at Dundee University to ...
bottom of page